The Arguments WHAT THE INDUSTRY ARGUES Supporters of the current Medicare Part D structure argue that its design—using multiple private plan options and formularies—was intended to promote competition among insurers and drive down costs for beneficiaries. The system allows flexibility so that different plans can negotiate drug prices independently, which proponents say ultimately benefits seniors…
The Arguments WHAT THE INDUSTRY ARGUES Insurance companies argue that medical necessity determinations protect patients from unnecessary or harmful treatments and help control healthcare costs. They employ clinical guidelines, evidence-based criteria, and review processes—sometimes involving licensed medical professionals—to evaluate whether a proposed treatment is appropriate for a patient’s specific diagnosis and condition. Insurers contend these…
The Arguments WHAT THE INDUSTRY ARGUES Proponents of the current claims system argue that claim denials serve as a necessary quality control mechanism, ensuring that billed services meet coverage criteria, are medically necessary, and are properly documented. The growing healthcare revenue cycle management market, projected to surpass $521 billion by 2035 according to SNS Insider,…
The Arguments WHAT THE INDUSTRY ARGUES Supporters of separate facility fees argue that hospitals must maintain emergency departments around the clock with specialized equipment, nursing staff, and infrastructure regardless of patient volume. The facility fee covers overhead costs such as building maintenance, regulatory compliance, emergency preparedness, and uncompensated care for uninsured patients. Without these fees,…
The Arguments WHAT THE INDUSTRY ARGUES Hospitals and industry defenders note that listed prices, known as chargemaster rates, are the starting point for all patients, but insurers negotiate discounts on behalf of their members. Uninsured patients see the full chargemaster price because no insurer is negotiating on their behalf. Some hospitals offer financial assistance or…
The Arguments WHAT THE INDUSTRY ARGUES Hospitals argue that the price of a single aspirin reflects more than the pill itself. The charge encompasses the infrastructure required to safely administer medication, including pharmacy oversight, nurse labor for delivery and documentation, electronic medical record systems, regulatory compliance, and around-the-clock staffing. Hospitals also note that facility costs,…
The Arguments WHAT THE INDUSTRY ARGUES Supporters of PBMs argue that these companies serve as intermediaries between health insurers, drug manufacturers, and pharmacies to negotiate drug prices and manage prescription drug benefits. Proponents contend that PBMs use their purchasing power to negotiate rebates and discounts from pharmaceutical companies, which can help lower costs for insurers…
The Arguments WHAT THE INDUSTRY ARGUES Advocates for bill negotiation point out that hospital pricing is often opaque and inflated, leaving room for patients to request reductions after the fact. As Slate Magazine reports, negotiating medical bills has saved patients meaningful amounts of money. With medical costs rising far faster than inflation and driving Americans…
The Arguments WHAT THE INDUSTRY ARGUES Proponents of Certificate of Need laws argue that these regulations prevent unnecessary duplication of healthcare services and facilities, which can drive up costs for everyone. By requiring state approval before building new facilities or expanding services, CON laws are intended to ensure that healthcare resources are distributed based on…
The Arguments WHAT THE INDUSTRY ARGUES Supporters of Certificate of Need laws argue they prevent unnecessary duplication of expensive healthcare services, ensure adequate care in underserved areas, and help control healthcare costs by requiring new facilities or major expansions to demonstrate community need before receiving state approval. Proponents contend that without CON requirements, market oversaturation…